Name: Aspire Biopharma Holdings, Inc. (ASBP) Balance Sheet
Creator: FinSpry

Aspire Biopharma Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aspire Biopharma Holdings, Inc. (ASBP) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	0.00	0.01	0.00
Cash & Short-Term Investments	0.00	0.01	0.00
Accounts Receivable	0.04	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.11	0.04	0.02
Total Current Assets	0.15	0.05	0.02
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00
Long-Term Investments	6.67	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00
Total Non-Current Assets	6.67	0.00	0.00
Total Assets	0.15	0.05	0.02
Current Liabilities
Accounts Payable	0.31	0.17	0.12
Short-Term Debt	1.27	0.36	0.03
Other Current Liabilities	0.11	0.00	0.00
Total Current Liabilities	1.69	0.53	0.15
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	3.85	0.00
Total Non-Current Liabilities	0.00	0.00	0.00
Total Liabilities	1.69	0.53	0.15
Stockholders' Equity
Common Stock	0.02	0.02	0.22
Retained Earnings	-2.78	-1.47	-1.11
Additional Paid-in Capital	1.22	0.96	0.76
Shares Outstanding	1.15	1.15	1.15
Total Stockholders' Equity	-1.54	-0.49	-0.13
Total Liabilities & Equity	0.15	0.05	0.02